-+ 0.00%
-+ 0.00%
-+ 0.00%

Enliven Therapeutics: Q4 Earnings Insights

Benzinga·03/03/2026 21:48:08
Listen to the news

Enliven Therapeutics (NASDAQ:ELVN) released its Q4 earnings on Tuesday, March 3, 2026 at 04:05 PM.

Here's what's important from the earnings announcement.

Earnings

Enliven Therapeutics missed estimated earnings by -6.67%, reporting an EPS of $-0.48 versus an estimate of $-0.45.

Revenue was down $0 from the same period last year.

Earnings History Overview

During the previous quarter, the company beat on EPS by $0.13, leading to a 0.15% drop share price change the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Enliven Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.